An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Taiho Oncology, Inc.
University Hospital Regensburg
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine